Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription

  1. Rui Gao
  2. Anirban Chakraborty
  3. Charlene Geater
  4. Subrata Pradhan
  5. Kara L Gordon
  6. Jeffrey Snowden
  7. Subo Yuan
  8. Audrey S Dickey
  9. Sanjeev Choudhary
  10. Tetsuo Ashizawa
  11. Lisa M Ellerby
  12. Albert R La Spada
  13. Leslie M Thompson
  14. Tapas K Hazra
  15. Partha S Sarkar  Is a corresponding author
  1. University of Texas Medical Branch, United States
  2. University of California, Irvine, United States
  3. Duke University School of Medicine, United States
  4. Sam Houston State University, United States
  5. Houston Methodist Research Institute, United States
  6. Buck Institute for Research on Aging, United States

Abstract

How huntingtin (HTT) triggers neurotoxicity in Huntington's disease (HD) remains unclear. We report that HTT forms a transcription-coupled DNA repair (TCR) complex with RNA polymerase II subunit A (POLR2A), ataxin-3, the DNA repair enzyme polynucleotide-kinase-3'-phosphatase (PNKP), and cyclic AMP-response element-binding (CREB) protein (CBP). This complex senses and facilitates DNA damage repair during transcriptional elongation, but its functional integrity is impaired by mutant HTT. Abrogated PNKP activity results in persistent DNA break accumulation, preferentially in actively transcribed genes, and aberrant activation of DNA damage-response ataxia telangiectasia-mutated (ATM) signaling in HD transgenic mouse and cell models. A concomitant decrease in Ataxin-3 activity facilitates CBP ubiquitination and degradation, adversely impacting transcription and DNA repair. Increasing PNKP activity in mutant cells improves genome integrity and cell survival. These findings suggest a potential molecular mechanism of how mutant HTT activates DNA damage-response pro-degenerative pathways and impairs transcription, triggering neurotoxicity and functional decline in HD.

Data availability

All data generated are included in the manuscript and supporting files.

Article and author information

Author details

  1. Rui Gao

    Department of Neurology, University of Texas Medical Branch, Galveston, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Anirban Chakraborty

    Department of Internal Medicine, University of Texas Medical Branch, Galveston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Charlene Geater

    Department of Psychiatry and Human Behavior, University of California, Irvine, Irvine, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Subrata Pradhan

    Department of Neurology, University of Texas Medical Branch, Galveston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Kara L Gordon

    Department of Neurology, Duke University School of Medicine, Durham, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Jeffrey Snowden

    Department of Neurology, University of Texas Medical Branch, Galveston, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Subo Yuan

    Department of Neuroscience, University of Texas Medical Branch, Galveston, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Audrey S Dickey

    Department of Neurology, Duke University School of Medicine, Durham, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Sanjeev Choudhary

    Department of Biochemistry, Cell Biology and Genetics, Sam Houston State University, Huntsville, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Tetsuo Ashizawa

    Department of Neurology, Houston Methodist Research Institute, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Lisa M Ellerby

    Buck Institute for Research on Aging, Novato, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Albert R La Spada

    Department of Neurology, Duke University School of Medicine, Durham, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6151-2964
  13. Leslie M Thompson

    Department of Psychiatry and Human Behavior, University of California, Irvine, Irvine, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Tapas K Hazra

    Department of Internal Medicine, University of Texas Medical Branch, Galveston, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Partha S Sarkar

    Department of Neurology, University of Texas Medical Branch, Galveston, United States
    For correspondence
    pssarkar@utmb.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2885-8100

Funding

NIH Office of the Director (NSO79541-01)

  • Tapas K Hazra
  • Partha S Sarkar

NIH Office of the Director (NS073976)

  • Tapas K Hazra

Hereditary Disease Foundation (Postdoctoral Fellowship)

  • Charlene Geater

Mitchel Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX (Developmental Grant)

  • Partha S Sarkar

NIH Office of the Director (EY026089-01A1)

  • Partha S Sarkar

NIH Office of the Director (NS100529)

  • Lisa M Ellerby

NIH Office of the Director (AG033082)

  • Albert R La Spada

NIH Office of the Director (NS065874)

  • Albert R La Spada

NIH Office of the Director (NS089076)

  • Leslie M Thompson

NIH Office of the Director (NS090390)

  • Leslie M Thompson

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All procedures involving animals were in accordance with the National Institutes of Health Guide for the care and use of Laboratory Animals, and approved by the Institutional Animal Care and Use Committee of University of California Irivine (protocol #: AUP-18-155); and Duke University (protocol #: A225-17-09).

Copyright

© 2019, Gao et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,188
    views
  • 874
    downloads
  • 100
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Rui Gao
  2. Anirban Chakraborty
  3. Charlene Geater
  4. Subrata Pradhan
  5. Kara L Gordon
  6. Jeffrey Snowden
  7. Subo Yuan
  8. Audrey S Dickey
  9. Sanjeev Choudhary
  10. Tetsuo Ashizawa
  11. Lisa M Ellerby
  12. Albert R La Spada
  13. Leslie M Thompson
  14. Tapas K Hazra
  15. Partha S Sarkar
(2019)
Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription
eLife 8:e42988.
https://doi.org/10.7554/eLife.42988

Share this article

https://doi.org/10.7554/eLife.42988

Further reading

    1. Neuroscience
    Gergely F Turi, Sasa Teng ... Yueqing Peng
    Research Article

    Synchronous neuronal activity is organized into neuronal oscillations with various frequency and time domains across different brain areas and brain states. For example, hippocampal theta, gamma, and sharp wave oscillations are critical for memory formation and communication between hippocampal subareas and the cortex. In this study, we investigated the neuronal activity of the dentate gyrus (DG) with optical imaging tools during sleep-wake cycles in mice. We found that the activity of major glutamatergic cell populations in the DG is organized into infraslow oscillations (0.01–0.03 Hz) during NREM sleep. Although the DG is considered a sparsely active network during wakefulness, we found that 50% of granule cells and about 25% of mossy cells exhibit increased activity during NREM sleep, compared to that during wakefulness. Further experiments revealed that the infraslow oscillation in the DG was correlated with rhythmic serotonin release during sleep, which oscillates at the same frequency but in an opposite phase. Genetic manipulation of 5-HT receptors revealed that this neuromodulatory regulation is mediated by Htr1a receptors and the knockdown of these receptors leads to memory impairment. Together, our results provide novel mechanistic insights into how the 5-HT system can influence hippocampal activity patterns during sleep.

    1. Neuroscience
    Ulrike Pech, Jasper Janssens ... Patrik Verstreken
    Research Article

    The classical diagnosis of Parkinsonism is based on motor symptoms that are the consequence of nigrostriatal pathway dysfunction and reduced dopaminergic output. However, a decade prior to the emergence of motor issues, patients frequently experience non-motor symptoms, such as a reduced sense of smell (hyposmia). The cellular and molecular bases for these early defects remain enigmatic. To explore this, we developed a new collection of five fruit fly models of familial Parkinsonism and conducted single-cell RNA sequencing on young brains of these models. Interestingly, cholinergic projection neurons are the most vulnerable cells, and genes associated with presynaptic function are the most deregulated. Additional single nucleus sequencing of three specific brain regions of Parkinson’s disease patients confirms these findings. Indeed, the disturbances lead to early synaptic dysfunction, notably affecting cholinergic olfactory projection neurons crucial for olfactory function in flies. Correcting these defects specifically in olfactory cholinergic interneurons in flies or inducing cholinergic signaling in Parkinson mutant human induced dopaminergic neurons in vitro using nicotine, both rescue age-dependent dopaminergic neuron decline. Hence, our research uncovers that one of the earliest indicators of disease in five different models of familial Parkinsonism is synaptic dysfunction in higher-order cholinergic projection neurons and this contributes to the development of hyposmia. Furthermore, the shared pathways of synaptic failure in these cholinergic neurons ultimately contribute to dopaminergic dysfunction later in life.